Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,250,051,454
+$166,920,794 QoQ
Shares Held
6,592,403
+20.0% QoQ
Ownership
0.425%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#34
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Derivatives in AZN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$15,169,600
PutShares
80,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $8,073,972,287 across 18 Drug Manufacturers - General names. AZN ranks #3 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,143,891 | $1,372,017,294 | |
| 2 | ABBV |
AbbVie Inc.
|
5,015,515 | $1,262,104,193 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
6,592,403 | $1,250,051,454 | |
| 4 | JNJ |
Johnson & Johnson
|
4,651,595 | $1,181,365,579 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,793,897 | $873,015,763 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,113,242 | $646,006,993 | |
| 7 | AMGN |
Amgen Inc
|
1,326,673 | $480,414,824 | |
| 8 | PFE |
Pfizer Inc
|
16,746,801 | $403,262,965 |
All Filings in AZN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,250,051,454 | 6,592,403 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $15,169,600 | 80,000 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $1,083,130,660 | 5,491,992 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,972,200 | 10,000 | Put | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||